Mersana Therapeutics Inc (NASDAQ: MRSN) kicked off on Tuesday, up 9.24% from the previous trading day, before settling in for the closing price of $1.84. Over the past 52 weeks, MRSN has traded in a range of $1.15-$6.28.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 12371.94%. While this was happening, its average annual earnings per share was recorded 53.15%. With a float of $90.06 million, this company’s outstanding shares have now reached $120.71 million.
Let’s determine the extent of company efficiency that accounts for 123 employees. In terms of profitability, gross margin is 94.32%, operating margin of -360.27%, and the pretax margin is -349.98%.
Mersana Therapeutics Inc (MRSN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Mersana Therapeutics Inc is 26.59%, while institutional ownership is 67.53%. The most recent insider transaction that took place on Oct 28 ’24, was worth 3,580. In this transaction SVP, Chief Development Officer of this company sold 1,884 shares at a rate of $1.90, taking the stock ownership to the 54,731 shares. Before that another transaction happened on Oct 28 ’24, when Company’s Officer proposed sale 1,884 for $2.04, making the entire transaction worth $3,843.
Mersana Therapeutics Inc (MRSN) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -0.35 earnings per share (EPS), higher than consensus estimate (set at -0.36) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.15% per share during the next fiscal year.
Mersana Therapeutics Inc (NASDAQ: MRSN) Trading Performance Indicators
Take a look at Mersana Therapeutics Inc’s (MRSN) current performance indicators. Last quarter, stock had a quick ratio of 2.72. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.86, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.70 in one year’s time.
Technical Analysis of Mersana Therapeutics Inc (MRSN)
Looking closely at Mersana Therapeutics Inc (NASDAQ: MRSN), its last 5-days average volume was 0.42 million, which is a drop from its year-to-date volume of 1.59 million. As of the previous 9 days, the stock’s Stochastic %D was 30.73%. Additionally, its Average True Range was 0.14.
During the past 100 days, Mersana Therapeutics Inc’s (MRSN) raw stochastic average was set at 73.83%, which indicates a significant increase from 61.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.15% in the past 14 days, which was lower than the 88.94% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8800, while its 200-day Moving Average is $2.7600. However, in the short run, Mersana Therapeutics Inc’s stock first resistance to watch stands at $2.1000. Second resistance stands at $2.1900. The third major resistance level sits at $2.3400. If the price goes on to break the first support level at $1.8600, it is likely to go to the next support level at $1.7100. Now, if the price goes above the second support level, the third support stands at $1.6200.
Mersana Therapeutics Inc (NASDAQ: MRSN) Key Stats
The company with the Market Capitalisation of 246.57 million has total of 122,675K Shares Outstanding. Its annual sales at the moment are 36,860 K in contrast with the sum of -171,670 K annual income. Company’s last quarter sales were recorded 2,290 K and last quarter income was -24,270 K.
